Murlentamab (Anti-AMHR2)
Murlentamab (Anti-AMHR2) is a humanized anti-AMHRII antibody targeting AMHRII. It suppresses tumor growth, stimulates the anti-tumor adaptive immune response through naive macrophage orientation and TAM reprogrammation, in ovarian tumor cells. MW :145.5 KD.
| Trivial name | 3C23K |
| Catalog Number | A2590 |
| CAS# | 2058047-65-5 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/murlentamab-anti-amhr2.html |